168 related articles for article (PubMed ID: 27336725)
21. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
22. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
Morimoto S; Takao M; Hatsuta H; Nishina Y; Komiya T; Sengoku R; Nakano Y; Uchino A; Sumikura H; Saito Y; Kanemaru K; Murayama S
PLoS One; 2017; 12(2):e0171524. PubMed ID: 28166276
[TBL] [Abstract][Full Text] [Related]
23. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
25. Frontotemporal lobar degeneration and dementia with Lewy bodies: clinicopathological issues associated with antemortem diagnosis.
Yokota O
Psychogeriatrics; 2009 Jun; 9(2):91-102. PubMed ID: 19604332
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.
Armstrong MJ; Song S; Kurasz AM; Li Z
J Alzheimers Dis; 2022; 86(4):1935-1946. PubMed ID: 35253760
[TBL] [Abstract][Full Text] [Related]
27. Color Vision Impairment Differentiates Alzheimer Dementia From Dementia With Lewy Bodies.
Flanigan PM; Khosravi MA; Leverenz JB; Tousi B
J Geriatr Psychiatry Neurol; 2018 Mar; 31(2):97-102. PubMed ID: 29658429
[TBL] [Abstract][Full Text] [Related]
28. Neuroimaging in dementia: a practical guide.
Mortimer AM; Likeman M; Lewis TT
Pract Neurol; 2013 Apr; 13(2):92-103. PubMed ID: 23468560
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the prevalence of orthostatic hypotension between older patients with Alzheimer's Disease, Lewy body dementia, and without dementia.
Isik AT; Kocyigit SE; Smith L; Aydin AE; Soysal P
Exp Gerontol; 2019 Sep; 124():110628. PubMed ID: 31173842
[TBL] [Abstract][Full Text] [Related]
30. Comparing the driving behaviours of individuals with frontotemporal lobar degeneration and those with Alzheimer's disease.
Fujito R; Kamimura N; Ikeda M; Koyama A; Shimodera S; Morinobu S; Inoue S
Psychogeriatrics; 2016 Jan; 16(1):27-33. PubMed ID: 25735319
[TBL] [Abstract][Full Text] [Related]
31. A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer's disease.
Breitve MH; Hynninen MJ; Brønnick K; Chwiszczuk LJ; Auestad BH; Aarsland D; Rongve A
Alzheimers Res Ther; 2016 Jan; 8():3. PubMed ID: 26812908
[TBL] [Abstract][Full Text] [Related]
32. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia.
Walker MP; Ayre GA; Cummings JL; Wesnes K; McKeith IG; O'Brien JT; Ballard CG
Neurology; 2000 Apr; 54(8):1616-25. PubMed ID: 10762503
[TBL] [Abstract][Full Text] [Related]
33. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.
Liu S; Jin Y; Shi Z; Huo YR; Guan Y; Liu M; Liu S; Ji Y
Aging Ment Health; 2017 Jun; 21(6):651-657. PubMed ID: 26882509
[TBL] [Abstract][Full Text] [Related]
34. Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration.
Katisko K; Haapasalo A; Koivisto A; Krüger J; Hartikainen P; Korhonen V; Helisalmi S; Herukka SK; Remes AM; Solje E
J Alzheimers Dis; 2018; 62(2):789-794. PubMed ID: 29480183
[TBL] [Abstract][Full Text] [Related]
35. Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration.
Seo SW; Thibodeau MP; Perry DC; Hua A; Sidhu M; Sible I; Vargas JNS; Gaus SE; Rabinovici GD; Rankin KD; Boxer AL; Kramer JH; Rosen HJ; Gorno-Tempini ML; Grinberg LT; Huang EJ; DeArmond SJ; Trojanowski JQ; Miller BL; Seeley WW
Neurology; 2018 Mar; 90(12):e1047-e1056. PubMed ID: 29453245
[TBL] [Abstract][Full Text] [Related]
36. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
Chaudhry A; Houlden H; Rizig M
J Neurol Sci; 2020 Aug; 415():116886. PubMed ID: 32428759
[TBL] [Abstract][Full Text] [Related]
37. 1H MR spectroscopy in common dementias.
Kantarci K; Petersen RC; Boeve BF; Knopman DS; Tang-Wai DF; O'Brien PC; Weigand SD; Edland SD; Smith GE; Ivnik RJ; Ferman TJ; Tangalos EG; Jack CR
Neurology; 2004 Oct; 63(8):1393-8. PubMed ID: 15505154
[TBL] [Abstract][Full Text] [Related]
38. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.
Malek-Ahmadi M; Beach TG; Zamrini E; Adler CH; Sabbagh MN; Shill HA; Jacobson SA; Belden CM; Caselli RJ; Woodruff BK; Rapscak SZ; Ahern GL; Shi J; Caviness JN; Driver-Dunckley E; Mehta SH; Shprecher DR; Spann BM; Tariot P; Davis KJ; Long KE; Nicholson LR; Intorcia A; Glass MJ; Walker JE; Callan M; Curry J; Cutler B; Oliver J; Arce R; Walker DG; Lue LF; Serrano GE; Sue LI; Chen K; Reiman EM
PLoS One; 2019; 14(6):e0217566. PubMed ID: 31237877
[TBL] [Abstract][Full Text] [Related]
39. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
Arai T; Mackenzie IR; Hasegawa M; Nonoka T; Niizato K; Tsuchiya K; Iritani S; Onaya M; Akiyama H
Acta Neuropathol; 2009 Feb; 117(2):125-36. PubMed ID: 19139911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
